Benitec Biopharma
BNTC
#7529
Rank
โ‚น37.79 B
Marketcap
โ‚น1,116
Share price
-3.41%
Change (1 day)
18.08%
Change (1 year)

Operating Margin for Benitec Biopharma (BNTC)

Operating Margin as of January 2026 (TTM): -26,082.70%

According to Benitec Biopharma 's latest financial reports and stock price the company's current Operating Margin is -26,082.70%. At the end of 2023 the company had an Operating Margin of -26,082.67%.

Operating Margin history for Benitec Biopharma from 2015 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2023-26,082.67%4.57%
2022-24,942.47%6.01%
2021-23,528.81%175.84%
2020-8,529.90%-37864.98%
201922.59%-100.99%
2018-2,279.66%73.77%
2017-1,311.89%-75.43%
2016-5,340.09%401.58%
2015-1,064.66%-15.03%
2014-1,253.01%0%
2013-1,253.01%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Nymox Pharmaceutical
NYMX
-234,760.00% 800.06% Bahamas
NRC Health
NRC
22.85%-100.09%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.